GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for ...

Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...

India’s obesity crisis is colliding with a transformative moment in treatment, as GLP-1 therapies and a key court ruling on ...

A large new trial falls short of experts’ expectations for combating the neurodegenerative disease. But there could still be ...

The WHO’s announcement came hours after Australia released a safety alert over the potential risk of suicidal thoughts and behaviours for people using the medicines.

Weight-loss jabs like Ozempic, Wegovy and Mounjaro started out as diabetes medications — but in the last few years, they’ve ...

Australia’s medicines regulator has issued a safety warning over the risk of suicidal thoughts and behaviour linked to drugs ...

Eli Lilly announced trial results for its weight-loss medication, orforglipron, in August. Orforglipron is a once-daily oral ...

Marketers are positioning weight-loss shots as cosmetic elixirs for anyone who wants to lose a few pounds. Doctors warn that ...

The Centers for Medicare and Medicaid Services announced lower prices on 15 costly prescription drugs under Medicare, ...

Novo Nordisk NVO reported disappointing top-line data from the two-year primary analysis of two late-stage studies evaluating ...